Evaluation of The Effect of Virtual Reality Glasses

NCT ID: NCT06474780

Last Updated: 2024-06-26

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 900 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2024-06-28
• Study Completion Date: 2024-08-25

Brief Summary

The study was planned as a randomized controlled study to evaluate the effect of virtual reality glasses used on anxiety and treatment compliance in outpatient cancer patients receiving chemotherapy. The sample of the study consisted of a total of 30 patients, including 15 experimental and 15 control groups, who received intravenous chemotherapy treatment every 21 days between April 1 and September 31, 2023, in the outpatient chemotherapy unit of a research hospital. Research data will be collected using the Patient Information Form, Beck Anxiety Scale (BAI) and Chronic Disease Adaptation Scale (CCDS). In evaluating the data, it was planned to analyze the differences between the rates of categorical variables in independent groups with Chi-Square tests. It was planned to use t tests to compare quantitative continuous data between two independent groups. Dependent groups t-test will be used to compare measurements within groups. After being informed about the research, patients in both groups will be given a pre-test. Patients in the experimental group will be shown 3 different videos with virtual reality glasses during 3 cycles of chemotherapy treatment, and a final test will be administered to both groups at the end of the 3rd cycle..

Conditions

Anxiety; Cancer; Chemotherapy; Virtual Reality; Treatment Compliance

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: PROSPECTIVE

Study Groups

experiment

Patients were informed about the study and patients who signed the informed consent form were included in the study. A pretest was applied to the patients. In the pre-test, data were collected using the "Patient Information Form", "Adaptation to Chronic Diseases Scale" and "Beck Anxiety Scale". Patients in the experimental group were shown videos of nature walks, forest walks and city tours of their choice for 15 minutes through virtual reality glasses 1 3 times in 21 days. At the end of the 3rd time, final tests were applied.

Weight: 414g Size: 19.5cm x 14cm x 11cm Compatibility: Android and iOS VR Box 3.0 3D Virtual Reality Glasses Has the Feature of Fixation with Headband It has a lens mechanism tha

Intervention Type: DEVICE

Patients in the experimental group were fitted with virtual reality glasses for 3 cycles and were allowed to watch videos of city tours, walks in the forest, and nature walks for 15 minutes, depending on their choice.

control

Patients were informed about the study and patients who signed the informed consent form were included in the study. A pretest was applied to the patients. In the pre-test, data were collected using the "Patient Information Form", "Adaptation to Chronic Diseases Scale" and "Beck Anxiety Scale". No application was made to the control group for 1.3 times in 21 days. Posttests were performed at the end of treatment for the third time.

No interventions assigned to this group

Interventions

Weight: 414g Size: 19.5cm x 14cm x 11cm Compatibility: Android and iOS VR Box 3.0 3D Virtual Reality Glasses Has the Feature of Fixation with Headband It has a lens mechanism tha

Patients in the experimental group were fitted with virtual reality glasses for 3 cycles and were allowed to watch videos of city tours, walks in the forest, and nature walks for 15 minutes, depending on their choice.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Being over 18 years old
• Knowing Turkish, agreeing to participate in the research
• Being diagnosed with cancer, regardless of the type of cancer
• Starting an intravenous chemotherapy treatment regimen after diagnosis
• Those who receive their treatment in 21-day periods to ensure equality in application frequencies.
• Able to use virtual reality glasses
• People without hearing or visual impairment are included

Exclusion Criteria

• Anyone with any visual or hearing impairment
• The patient does not know the diagnosis of cancer, has been diagnosed with cancer but has not received treatment or has completed the cure.
• Those with brain tumor or brain metastasis are not included.

• Minimum Eligible Age: 42 Years
• Maximum Eligible Age: 62 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Gozde Oz

OTHER

Sponsor Role: lead

Responsible Party

Gozde Oz

Research assistant

Responsibility Role: SPONSOR_INVESTIGATOR

Central Contacts

GÖZDE ÖZ

Role: CONTACT

gozde_srdal@hotmail.com

05367022644

Other Identifiers

44.2023fbu

Identifier Type: -

Identifier Source: org_study_id